Institution
Temple University
Education•Philadelphia, Pennsylvania, United States•
About: Temple University is a education organization based out in Philadelphia, Pennsylvania, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 32154 authors who have published 64375 publications receiving 2219828 citations.
Topics: Population, Poison control, Anxiety, Context (language use), Medicine
Papers published on a yearly basis
Papers
More filters
TL;DR: In this article, the authors identify the most critical strategic, tactical, and information-gathering activities influencing the launch success, and then use a retrospective methodology to gather managerial perceptions regarding launch activities pertaining to a recent new product launch, and the product performance in terms of profitability, market share, and relative sales.
355 citations
TL;DR: Using mouse melanoma models, it is reported that CD8+ TILs enhance peroxisome proliferator-activated receptor (PPAR)-α signaling and catabolism of fatty acids (FAs) when simultaneously subjected to hypoglycemia and hypoxia.
354 citations
TL;DR: The study of JCV and the elucidation of the underlying causes of PML are important and active areas of research that may lead to new insights into immune function and host antiviral defense, as well as to potential new therapies.
Abstract: Summary: Progressive multifocal leukoencephalopathy (PML) is a debilitating and frequently fatal central nervous system (CNS) demyelinating disease caused by JC virus (JCV), for which there is currently no effective treatment. Lytic infection of oligodendrocytes in the brain leads to their eventual destruction and progressive demyelination, resulting in multiple foci of lesions in the white matter of the brain. Before the mid-1980s, PML was a relatively rare disease, reported to occur primarily in those with underlying neoplastic conditions affecting immune function and, more rarely, in allograft recipients receiving immunosuppressive drugs. However, with the onset of the AIDS pandemic, the incidence of PML has increased dramatically. Approximately 3 to 5% of HIV-infected individuals will develop PML, which is classified as an AIDS-defining illness. In addition, the recent advent of humanized monoclonal antibody therapy for the treatment of autoimmune inflammatory diseases such as multiple sclerosis (MS) and Crohn's disease has also led to an increased risk of PML as a side effect of immunotherapy. Thus, the study of JCV and the elucidation of the underlying causes of PML are important and active areas of research that may lead to new insights into immune function and host antiviral defense, as well as to potential new therapies.
354 citations
TL;DR: While the topics of business ethics and social responsibility education have received much attention in scholarly and pedagogical literature as discussed by the authors, the authors of this paper focus on the business ethics education.
Abstract: While the topics of business ethics and social responsibility education have received much attention in scholarly and pedagogical literature (although less in the pedagogical literature), the autho...
354 citations
TL;DR: Risk of noncancer deaths now surpasses that of cancer deaths, particularly for young patients in the year after diagnosis, particularly if they are diagnosed with testicular cancer.
354 citations
Authors
Showing all 32360 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Robert J. Lefkowitz | 214 | 860 | 147995 |
| Rakesh K. Jain | 200 | 1467 | 177727 |
| Virginia M.-Y. Lee | 194 | 993 | 148820 |
| Yury Gogotsi | 171 | 956 | 144520 |
| Timothy A. Springer | 167 | 669 | 122421 |
| Ralph A. DeFronzo | 160 | 759 | 132993 |
| James J. Collins | 151 | 669 | 89476 |
| Robert J. Glynn | 146 | 748 | 88387 |
| Edward G. Lakatta | 146 | 858 | 88637 |
| Steven Williams | 144 | 1375 | 86712 |
| Peter Buchholz | 143 | 1181 | 92101 |
| David Goldstein | 141 | 1301 | 101955 |
| Scott D. Solomon | 137 | 1145 | 103041 |
| Donald B. Rubin | 132 | 515 | 262632 |
| Jeffery D. Molkentin | 131 | 482 | 61594 |